FindTrial
Sign In

A study to assess the rate of occurence of nausea and vomiting followed by the addition of the drug morphine given as apart of anaesthesia for patients with carcinoma cervix undergoing high dose (HDR) intracavitary brachytherapy.

Prospective observational study to assess the incidence of nausea and vomiting following intrathecal morphine given as apart of anaesthesia for patients with carcinoma cervix undergoing high dose rate (HDR) intracavitary brachytherapy.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/025687
Enrollment
200
Registered
2020-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: Intra Thecal Morphine given as part of anaesthesia: Intra Thecal Morphine given as part of anaesthesia Intervention2: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Christian MedicalCollegeVellore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Histologically proven carcinoma cervix for intracavitary brachytherapy. 2) ASA I/II 3) Consent for participation in study

Exclusion criteria

Exclusion criteria: 1) Patient undergoing treatment for chronic pain 2) Preoperative history of nausea and vomiting requiring treatment 3) Unfit for spinal anaesthesia like Coagulopathy, cardiac lesions, infection at the site of spinal injection, fever 4) Unwilling or unable to give consent

Design outcomes

Primary

MeasureTime frame
Incidence of nausea and vomiting following intrathecal morphine among patients coming for HDR Brachytherapy for carcinoma cervixTimepoint: With in 24 hours—

Secondary

MeasureTime frame
i) Duration of analgesia with intrathecal morphine which will be measured by the time to first rescue analgesic ii) Incidence of side effects like sedation, pruritus, respiratory depression measured by sedation score, monitoring of respiratory rate and oxygen saturation at regular intervalsTimepoint: With in 24 hrs of induction—

Countries

India

Contacts

Public ContactDivya Isac

Christian Medical College

divyaishac@gmail.com944300580

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026